PATENT CLAIM ANALYSIS

Application Number: 16277689
Application Type: Utility
Filing Date: 2019-02
Publication Date: 2019-06
Patent Classification: ["424", "045000"]

Abstract:
The disclosure provides a method of treating chronic cough in a subject having idiopathic pulmonary fibrosis (IPF) comprising administering to the subject a pharmaceutical composition comprising from about 2% by weight to about 6% by weight of cromolyn sodium and an ionic osmotic agent with a nebulizer.

Claim (Index 8):
The method of  claim 1 , wherein the subject is administered one or more doses of cromolyn. or a pharmaceutically acceptable salt thereof.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 99.0
- Lexical Diversity: 1.26829
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15887830', '15750811', '15750809', '14686535', '16273987']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8060954374972199
- 35 USC 102 Novelty (BERT): 0.6217926213507856
- Combined Prediction Score: 0.7876651558825765
- Mean Citation Score: 431.317602
- Max Citation Score: 721.60675
- Similarity Product: 480.26287313827874

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test